ALG vs BMRN · P/E 23, rev $1.63B vs P/E 40, rev $2.85B
Alamo Group Inc (ALG) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Alamo Group Inc (ALG) is a farm & heavy construction machinery company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ALG revenue for 2024-12-31 was $1.63B. Net income was $115.9M. Revenue was down 3.6% from 2023-12-31 to 2024-12-31. ALG currently screens at market cap $2.72B and trailing P/E 23.3.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ALG currently screens at market cap $2.72B and trailing P/E 23.3. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ALG and BMRN stock pages for the full models.
Not investment advice.